Molecular Targeting in Oncology Image close
Molecular Targeting in Oncology on Hardback
Molecular Targeting in Oncology on Hardback
Show Hide Adult Content
Molecular Targeting in Oncology close

Non-Fiction Books:

Home  
Books  
Non-Fiction  
Professional & Technical  
Medicine  
Clinical & internal medicine  
Diseases & disorders  
Oncology  
Chemotherapy

Molecular Targeting in Oncology

Click to share your rating 0 ratings (0.0/5.0 average) Thanks for your vote!

Format:

Hardback
$601.00
Available from supplier

The item is brand new and in-stock with one of our preferred suppliers. The item will ship from a Mighty Ape warehouse within the timeframe shown.

Usually ships in 3-4 weeks
0 in Trolley
Free Delivery with Primate
Join Now

Free 14 day free trial, cancel anytime.

Buy Now, Pay Later with:

4 payments of $150.25 with Afterpay Learn more

6 weekly interest-free payments of $100.17 with Laybuy Learn more

Availability

Delivering to:

Estimated arrival:

  • Around 11-21 June using International Courier

Explore more Cancer Drug Discovery and Development

See all products in this series

Platinum-Based Drugs in Cancer Therapy on Hardback
$454.00
Platinum-Based Drugs in Cancer Therapy
Hardback
Available - Usually ships in 3-4 weeks
Tumor Targeting in Cancer Therapy on Hardback
$591.00
Tumor Targeting in Cancer Therapy
Hardback
Available - Usually ships in 3-4 weeks
Cytokines in the Genesis and Treatment of Cancer
$589.00
Cytokines in the Genesis and Treatment of Cancer
Paperback / softback
Available - Usually ships in 3-4 weeks
Camptothecins in Cancer Therapy on Hardback
$589.00
Camptothecins in Cancer Therapy
Hardback
Available - Usually ships in 3-4 weeks
Nitric Oxide (NO) and Cancer on Hardback
$591.00
Nitric Oxide (NO) and Cancer
Hardback
Available - Usually ships in 3-4 weeks
Antibody-Drug Conjugates and Immunotoxins on Hardback
$455.00
Antibody-Drug Conjugates and Immunotoxins
Hardback
Available - Usually ships in 3-4 weeks
BRAF Targets in Melanoma
$293.00
BRAF Targets in Melanoma
Paperback / softback
Available - Usually ships in 3-4 weeks
Apoptosis and Cancer Chemotherapy
$322.00
Apoptosis and Cancer Chemotherapy
Paperback / softback
Available - Usually ships in 3-4 weeks
Non-Hodgkin Lymphoma on Hardback
$453.00
Non-Hodgkin Lymphoma
Hardback
Available - Usually ships in 3-4 weeks
The Oncogenomics Handbook on Hardback
$604.00
The Oncogenomics Handbook
Hardback
Available - Usually ships in 3-4 weeks
BRAF Targets in Melanoma on Hardback
$295.00
BRAF Targets in Melanoma
Hardback
Available - Usually ships in 3-4 weeks
STAT Inhibitors in Cancer
$450.00
STAT Inhibitors in Cancer
Paperback / softback
Available - Usually ships in 3-4 weeks
Increasing the Therapeutic Ratio of Radiotherapy on Hardback
$452.00
Increasing the Therapeutic Ratio of Radiotherapy
Hardback
Available - Usually ships in 3-4 weeks
Targets for Cancer Chemotherapy
$324.00
Targets for Cancer Chemotherapy
Paperback / softback
Available - Usually ships in 3-4 weeks
Bioinformatics in Cancer and Cancer Therapy
$578.00
Bioinformatics in Cancer and Cancer Therapy
Paperback / softback
Available - Usually ships in 3-4 weeks
Molecular Targeted Radiosensitizers
$446.00
Molecular Targeted Radiosensitizers
Paperback / softback
Available - Usually ships in 3-4 weeks

Description

In Molecular Targeting in Oncology, authors present an overview of the development of targeted therapies for the treatment of cancer with an emphasis on clinical application. The volume covers the complexity of the rapidly developing area of targeted therapies for the treatment of patients with cancer and is structured in a way so readers may begin with chapters that most interest them and work through the rest of the chapters in the order of their choice. The volume is divided into five sections that cover the most important elements of drug development. The first section focuses on approaches using targeted therapies to inhibit cell growth. The second section describes how clinicians are evaluating targeted therapies in specific organ systems. The third section illustrates how various classes of pharmacologic and immunologic agents are developed for individual molecular targets. The fourth section details new drugs that have novel mechanisms of action. The final section looks to the future of targeted therapeutics and includes chapters on appropriate patient selection, use of combination therapy, dealing with tumor cell resistance, and more.
Release date NZ
January 7th, 2008
Audience
  • Professional & Vocational
Contributors
  • Edited by Howard L. Kaufman
  • Edited by Karen Antman
  • Edited by Scott Wadler
Illustrations
XVI, 728 p.
Pages
728
Dimensions
178x254x39
ISBN-13
9781588295774
Product ID
2429479

Customer reviews

Nobody has reviewed this product yet. You could be the first!

Write a Review

Marketplace listings

There are no Marketplace listings available for this product currently.
Already own it? Create a free listing and pay just 9% commission when it sells!

Sell Yours Here

Recommended for you

Recommended from your browsing history

Help & options

Filed under...

Books >
Non-Fiction >
Professional & Technical >
Medicine >
Clinical & internal medicine >
Diseases & disorders >
Oncology >
Chemotherapy
Books >
Non-Fiction >
Professional & Technical >
Medicine >
Clinical & internal medicine >
Diseases & disorders >
Oncology
Books >
Non-Fiction >
Professional & Technical >
Medicine >
Other branches of medicine >
Pharmacology